{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:36:42Z","timestamp":1794487002426,"version":"4.9.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jdsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jdermsci.2021.07.006","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T21:17:13Z","timestamp":1626211033000},"page":"63-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Contribution to the peripheral vasculopathy and endothelial cell dysfunction by CXCL4 in Systemic Sclerosis"],"prefix":"10.1016","volume":"104","author":[{"given":"Zhixing","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minrui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2021.07.006_bib0005","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrrheum.2010.102","article-title":"Cellular and molecular aspects of vascular dysfunction in systemic sclerosis","volume":"6","author":"Trojanowska","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0010","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"Van Den Hoogen","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11926-017-0684-2","article-title":"Very early systemic sclerosis and pre-systemic sclerosis: definition, recognition, clinical relevance and future directions","volume":"19","author":"Bellando-Randone","year":"2017","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0020","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13075-017-1370-5","article-title":"The \u201cmyth\u201d of loss of angiogenesis in systemic sclerosis: a pivotal early pathogenetic process or just a late unavoidable event?","volume":"19","author":"Matucci-Cerinic","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2017.08.021","article-title":"CXCL4-induced macrophages in human atherosclerosis","volume":"122","author":"Domschke","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cyto.2018.02.022","article-title":"CXCL4 and CXCL4L1 in cancer","volume":"109","author":"Ruytinx","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0035","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s13075-016-1203-y","article-title":"Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease","volume":"18","author":"Volkmann","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0040","first-page":"433","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"Van Bon","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0045","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1160\/TH10-03-0193","article-title":"Interaction of PF4 (CXCL4) with the vasculature: a role in atherosclerosis and angiogenesis","volume":"104","author":"Aidoudi","year":"2010","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0050","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/s41467-019-09683-z","article-title":"CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-alpha production in systemic sclerosis","volume":"10","author":"Lande","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0055","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"Van Den Hoogen","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0060","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.2010.136929","article-title":"Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group","volume":"70","author":"Avouac","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0065","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1136\/annrheumdis-2013-203716","article-title":"Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis","volume":"73","author":"Minier","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0070","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"Leroy","year":"2001","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0075","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1002\/art.23968","article-title":"Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions","volume":"58","author":"Avouac","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0080","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2249.2000.01115.x","article-title":"Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis","volume":"119","author":"Ihn","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0085","doi-asserted-by":"crossref","first-page":"e85032","DOI":"10.1371\/journal.pone.0085032","article-title":"IL-17A induces endothelial inflammation in systemic sclerosis via the ERK signaling pathway","volume":"8","author":"Xing","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0090","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/art.24502","article-title":"Improved endothelial function after endothelin receptor blockade in patients with systemic sclerosis","volume":"60","author":"Cardillo","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0095","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12016-015-8500-0","article-title":"Endothelial dysfunction and nailfold videocapillaroscopy pattern as predictors of digital ulcers in systemic sclerosis: a cohort study and review of the literature","volume":"49","author":"Silva","year":"2015","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0100","article-title":"Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis","author":"Miyagawa","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0105","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jdermsci.2018.09.005","article-title":"Progranulin overproduction due to constitutively activated c-Abl\/PKC-\u03b4\/Fli1 pathway contributes to the resistance of dermal fibroblasts to the anti-fibrotic effect of tumor necrosis factor-\u03b1 in localized scleroderma","volume":"92","author":"Miyagawa","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0110","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/art.39062","article-title":"Endothelin receptor blockade ameliorates vascular fragility in endothelial cell-specific Fli-1-knockout mice by increasing Fli-1 DNA binding ability","volume":"67","author":"Akamata","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0115","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature14119","article-title":"Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation","volume":"519","author":"Pemovska","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0120","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.autrev.2011.04.019","article-title":"Angiogenic cytokines and growth factors in systemic sclerosis","volume":"10","author":"Liakouli","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0125","first-page":"S46","article-title":"Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis","volume":"29","author":"Riccieri","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1359-6101(96)00048-2","article-title":"Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity","volume":"8","author":"Pepper","year":"1997","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0135","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.2741\/3573","article-title":"Transforming growth factor-beta signaling and tumor angiogenesis","volume":"14","author":"Pardali","year":"2009","journal-title":"Front Biosci."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0140","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1083\/jcb.125.4.917","article-title":"PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors","volume":"125","author":"Battegay","year":"1994","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0145","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nm848","article-title":"Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2","volume":"9","author":"Cao","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0150","doi-asserted-by":"crossref","first-page":"6834","DOI":"10.1038\/onc.2008.287","article-title":"Glioblastoma-secreted factors induce IGFBP7 and angiogenesis by modulating Smad-2-dependent TGF-beta signaling","volume":"27","author":"Pen","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0155","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/ph3030572","article-title":"Platelet-derived growth factor (PDGF)\/PDGF receptors (PDGFR) Axis as target for antitumor and antiangiogenic therapy","volume":"3","author":"Raica","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0160","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/cas.12548","article-title":"Inhibition of transforming growth factor beta\/SMAD signal by MiR-155 is involved in arsenic trioxide-induced anti-angiogenesis in prostate cancer","volume":"105","author":"Ji","year":"2014","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0165","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.canlet.2013.01.006","article-title":"Platelet factor-4 (CXCL4\/PF-4): an angiostatic chemokine for cancer therapy","volume":"331","author":"Wang","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0170","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/jnci\/82.10.848","article-title":"Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4","volume":"82","author":"Sharpe","year":"1990","journal-title":"JNCI"},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0175","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"Van Bon","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0180","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1084\/jem.20160247","article-title":"Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: possible roles in scleroderma","volume":"214","author":"Takahashi","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0185","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/art.39062","article-title":"Endothelin receptor blockade ameliorates vascular fragility in endothelial cell\u2013Specific Fli\u20101\u2013Knockout mice by increasing Fli\u20101 DNA binding ability","volume":"67","author":"Akamata","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0190","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/ar4529","article-title":"Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1","volume":"16","author":"Akamata","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0195","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/ard.2010.143974","article-title":"Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial","volume":"70","author":"Spiera","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0200","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1002\/art.30549","article-title":"Imatinib in active diffuse cutaneous systemic sclerosis: results of a six\u2010month, randomized, double\u2010blind, placebo\u2010controlled, proof\u2010of\u2010concept pilot study at a single center","volume":"63","author":"Pope","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0205","doi-asserted-by":"crossref","first-page":"6507","DOI":"10.1158\/0008-5472.CAN-15-2864","article-title":"Dual roles for CXCL4 chemokines and CXCR3 in angiogenesis and invasion of pancreatic cancer","volume":"76","author":"Quemener","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0210","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11926-011-0219-1","article-title":"Angiogenesis and vasculopathy in systemic sclerosis: evolving concepts","volume":"14","author":"Rabquer","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0215","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/annrheumdis-2014-206921","article-title":"Expression of chemokines CXCL4 and CXCL7 by synovial macrophages defines an early stage of rheumatoid arthritis","volume":"75","author":"Yeo","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0220","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fphys.2014.00294","article-title":"Platelets and their chemokines in atherosclerosis-clinical applications","volume":"5","author":"Von Hundelshausen","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0225","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijcard.2015.03.151","article-title":"Prevalence of M4 macrophages within human coronary atherosclerotic plaques is associated with features of plaque instability","volume":"186","author":"Erbel","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0230","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1038\/ncomms6797","article-title":"Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis","volume":"5","author":"Noda","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0235","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/art.41423","article-title":"Altered properties of endothelial cells and mesenchymal stem cells underlying the development of scleroderma-like vasculopathy in KLF5(+\/-) ;Fli-1(+\/-) mice","volume":"72","author":"Nakamura","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0240","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00795-015-0107-2","article-title":"Double heterozygous mice for Klf5 and Fli1 genes: a new animal model of systemic sclerosis recapitulating its three cardinal pathological features","volume":"48","author":"Asano","year":"2015","journal-title":"Med. Mol. Morphol."},{"key":"10.1016\/j.jdermsci.2021.07.006_bib0245","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/rheumatology\/keu479","article-title":"Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis","volume":"54","author":"Akamata","year":"2015","journal-title":"Rheumatology (Oxford)"}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181121001729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181121001729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T04:52:29Z","timestamp":1760331149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181121001729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0923181121001729"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2021.07.006","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-46094\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-41064\/v1","asserted-by":"object"}]},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contribution to the peripheral vasculopathy and endothelial cell dysfunction by CXCL4 in Systemic Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2021.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V. on behalf of Japanese Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}